- Published at
- by globenewswire.com
positive
positive
Medexus Achieves Record Revenue of $31.5 Million for the Third Quarter Fiscal 2021
Management to host conference call at 8:00 AM Eastern Time on Tuesday, March 2, 2021
News for Aptevo Therapeutics Inc. (AP8N.F)
- Published at
- by markets.businessinsider.com
positivepositiveAlligator Bioscience AB: Year-end Report January-December 2020
Continued focus on clinical development.STOCKHOLM, Feb. 26, 2021 /PRNewswire/ -- 'Safety data has been presented from the ongoing Phase I study wi...- Published at
- by markets.businessinsider.com
positivepositiveAlligator Bioscience AB: Year-end Report January-December 2020
STOCKHOLM, Feb. 26, 2021 /PRNewswire/ -- 'Safety data has been presented from the ongoing Phase I study with ATOR-1017 in patients with metastatic...- Published at
- by benzinga.com
mixedmixedThe Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 10) 9 ...XUPB.MUXUPB.FXUPB.BEXUP.MUXUP.FXUP.BESQZSAVARGO.SGRGO.MURGO.FRGO.BEREGN.MXREGNPX91.MUPX91.FPX91.BEPLX.TAPLXPBDA.MUPBDA.FPBDA.BENARILGNDLGDN.FLGDN.BEKTRAKRTXKALVJAZZN.MXJAZZJ7Z.SGJ7Z.MUJ7Z.FJ7Z.BEITRMITOSITCIILMNGNFTFGNFT.PAGNFTGMDAENLV.TAENLVDMPWWCDAK4XC1.SG4XC1.F4XC1.BE3DM.F3DM.BE32W.MU32W.F23I.MU23I.F23I.BE1BT.F1BT.BEVNDAVM4.SGVM4.FUG2.SGUG2.FUG2.BETXMDTEVAN.MXTEVATEV.FTERNSYBXSWTXSU6.FSU6.BESRDXSLRXSESNSEELRV7.MURV7.FRV7.BERGLSRDUSRCUSQIA.SGQIA.MUQIA.FQIA.DEQIA.BEQGENPYPDPRTKPRTAPRLDPDSBPCBK.MUPCBK.FPCBK.BEPACBP09.SGP09.FP09.BEOTLKOPNTO7PA.MUO7PA.FNXEN.SGNXEN.FNXEN.BENVV1.MUNVV1.FNVV1.BENVCRNVAX.MXNVAXNOVNNMTRNKNBSEN4CN.SGN4CN.FN4CN.BEMREOMORFMINA.MUMINA.FMINA.BEMDXGMAH0.SGMAH0.MUMAH0.FMAH0.BEKMDA.TAKMDAINSPILU.SGILU.MUILU.FILU.DEILU.BEILMN.MXIDYAHAZ.MUHAZ.FHALOHAEGKOSGHSIFP11.FFLGT.MXFLGTFLDMFLB.MUFLB.FFLB.BEEYENEXELEX9.MUEX9.FEX9.DEEX9.BEEVGN.TAEVGNEU6.FETONEJU.MUEJU.FEJU.BEEDAPEDA.FEDA.BEDRIOCXF.MUCXF.FCXF.BECOLLCMRXCLPTCELCCCXICBMGBBIOASLNARGX.BRARGXAPVOAP8N.MUAP8N.FANGOAMRXAGIOAEMDABCL8QQ.HM8AP.MU8AP.F7RG1.F7F0.F7F0.BE7A9.MU7A9.F7A9.BE6LU.F6LU.BE6GJ.F41ON.SG41ON.MU41ON.F41ON.BE354.F31Y.MU31Y.F30J.MU30J.F30J.BE2Q3.F2Q3.BE2DR.MU2DR.F2DR.BE2CX.SG2CX.MU2CX.BE2CL.MU2CL.F29T.F29T.BE1R8.SG1R8.F1R8.BE1AEA.MU1AE.SG1AE.MU1AE.F1AE.BE0PT.F038.MU038.F038.DUZSANXNCRXE9.SGXE9.MUXE9.FXE9.BEVRCAVERUVCYTVCELLLY.SGLLY.FLLY.DELLY.BALLYFMW.MUFMW.FFMW.BEATQP.SGATQP.MUATQP.FATQP.BE1NE.MU1NE.F12V.F12V.BE0ZPN.SG0ZPN.F0ZPN.BE- Published at
- by zacks.com
positivepositiveAptevo Therapeutics Inc. (APVO) Upgraded to Buy: Here's Why
Aptevo Therapeutics Inc. (APVO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).